Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

8.2K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.2K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

835
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
835
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

6.9K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.9K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

5.5K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.5K
Protein-protein Interfaces02:04

Protein-protein Interfaces

12.6K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.6K
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

1.1K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of the therapeutic effect of new hypoglycemic drugs on patients with heart failure with reduced ejection fraction and type 2 diabetes: a systematic review and network meta-analysis.

Frontiers in cardiovascular medicine·2026
Same author

scALGSL: Active Learning and Graph Structure Learning for Cell Type Annotation From Single-Cell RNA-seq Data.

IEEE transactions on computational biology and bioinformatics·2026
Same author

scTECTA: Asymmetric Deep Transfer Learning for Cross-Patient Tumor Microenvironment Single-Cell Annotation.

IEEE transactions on computational biology and bioinformatics·2025
Same author

A Multisource Transformer-Guided Graph Representation Learning Framework for circRNA-Disease Association Prediction.

ACS omega·2025
Same author

scGraphDap: Integrating Functional State Pseudo-Labels and Graph Structure Learning for Robust Cell Type Annotation in Tumor Microenvironments.

IEEE journal of biomedical and health informatics·2025
Same author

Survey and analysis of the prevalence of tobacco use among patients with severe mental illness at a tertiary specialized psychiatric medical center in China.

Frontiers in psychiatry·2025
Same journal

Tumor-derived apoptotic extracellular vesicles impede hepatocarcinoma progression by disrupting mitochondrial metabolism.

Journal of translational medicine·2026
Same journal

CAR-Macrophage therapy for digestive system tumors: mechanisms, engineering and translational prospects.

Journal of translational medicine·2026
Same journal

hsa_circ_0063865 regulates cytoskeleton rearrangement and endoplasmic reticulum stress to promote esophageal tumorigenesis under co-exposure to N-nitrosamines and microcystin.

Journal of translational medicine·2026
Same journal

Metabolic regulation of macrophage polarization in myocardial infarction: from mechanisms to targeted therapies.

Journal of translational medicine·2026
Same journal

Involvement of Fibulin-5 in endothelial to mesenchymal transition leading to cardiac fibrosis during metabolic syndrome.

Journal of translational medicine·2026
Same journal

Minimally invasive circulating MicroRNA signatures for breast cancer detection and neoadjuvant therapy response prediction in a multicenter MENA cohort.

Journal of translational medicine·2026
See all related articles

Related Experiment Video

Updated: Aug 12, 2025

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.2K

DeepMPF: deep learning framework for predicting drug-target interactions based on multi-modal representation with

Zhong-Hao Ren1, Zhu-Hong You2, Quan Zou3

  • 1School of Information Engineering, Xijing University, Xi'an, 710100, China.

Journal of Translational Medicine
|January 26, 2023
PubMed
Summary
This summary is machine-generated.

DeepMPF, a novel computational framework, accurately predicts drug-target interactions by integrating multi-modal data and meta-path semantic analysis. This approach enhances drug discovery by identifying potential drug candidates more efficiently than traditional methods.

Keywords:
Drug–protein interactionsJoint learningMeta-pathMulti-modalNatural language processingSequence analysis

More Related Videos

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.2K
Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.8K

Related Experiment Videos

Last Updated: Aug 12, 2025

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.2K
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.2K
Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.8K

Area of Science:

  • Computational biology
  • Bioinformatics
  • Drug discovery and development

Background:

  • Drug-target interaction (DTI) prediction is vital for drug design but faces challenges due to complex biological and chemical spaces.
  • Traditional experimental methods for DTI prediction are time-consuming and costly.
  • Existing computational methods often fail to fully leverage heterogeneous biological network structures and multi-modal information for accurate DTI prediction.

Purpose of the Study:

  • To develop a multi-modal representation framework, DeepMPF, for accurate drug-target interaction prediction.
  • To effectively utilize heterogeneous information and meta-path semantic analysis to improve DTI prediction accuracy.
  • To provide a computational tool for prescreening potential drug candidates.

Main Methods:

  • Constructed protein-drug-disease heterogeneous networks.
  • Extracted feature information from sequence, heterogeneous structure, and similarity modalities.
  • Employed six representative meta-path schemas for capturing high-order network structures and hidden information.
  • Generated comprehensive feature descriptors and performed joint learning to predict interaction probabilities.

Main Results:

  • DeepMPF achieved competitive predictive performance across four gold standard datasets.
  • Drug repositioning experiments for COVID-19 and HIV demonstrated the practical applicability of DeepMPF.
  • Molecular docking experiments validated the credibility of drug candidates predicted by DeepMPF.

Conclusions:

  • DeepMPF effectively predicts drug-target interactions, offering a valuable tool for computational drug discovery.
  • The framework enhances the efficiency of prescreening potential drug candidates for proteins.
  • A publicly available web server for DeepMPF facilitates further research in the field.